Neuropharmacology and Neurotechnology
Studies of drug effects on neural systems forms an important cornerstone of both our basic research and clinical treatments.
Our work extends from using established neuromodulators to investigate neural circuit activity to Phase 2 drug trials of novel therapies. The development of new drugs and applications arises from our close partnerships with the pharmaceutical sector, both in conducting basic neuroscience research and testing the efficacy of new products.
Working within a consortium of regional universities, we have a particular interest in natural products pharmacology and the application of these products to novel therapies. Our research in neurotoxicology spans both natural toxins that interfere with neurotransmission and chemicals that disrupt normal neural activity and may trigger pathology. Research in drug addictions span range from the basic mechanism underlying drug dependence and relapse, to the perceptual changes in cognitive function arising from recreational drug use. In addition to drug treatments, the Institute as a growing portfolio of projects developing implants both for research purposes and clinical treatment. This programme builds on expertise in nanotechnology and electronics and includes motor and visual prosthetic devices.
The following pages provide more information on these topics:
- Neuropharmacology
- Drug Addictions
- Neurotoxicology
- Natural Products Pharmacology
- Neural Prosthetics and Neurotechnology
